PHOENIX (Sept. 26, 2023) – Newsweek has again named Barrow Neurological Institute one of the World’s Best Specialized Hospitals for Neurosurgery.
In its third year of ranking hospitals in neurosurgery, the media company continues to recognize Barrow as No. 1 in the Southwest and No. 10 in the nation. The Institute climbed two spots globally, sitting at No. 13 for 2024. The list includes 125 hospitals total.Continue reading
PriZm Therapeutics, a late-stage clinical biotech company with a focus on rare pediatric orphan diseases and BIO’s Seed-Stage Start-Up Stadium winner was featured nationally and Internationally in BIO News. Continue reading
Thanks to a collaboration between the Office of the Maricopa County School Superintendent and the Flinn Foundation, Arizona Bioscience Week will be celebrated in classrooms across Arizona as teachers and students explore pathways to life science and bioscience careers.Continue reading
San Francisco, CA — September 21, 2023 — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.
Continue reading
AZBio Board Member Dr. Steve Potts was in Washington, D.C. on Wednesday, September 20, 2023. He testified in the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee on how the Inflation Reduction Act’s price setting provisions are already raising the hurdles for health innovators as they race to develop new small molecule treatments and cures. Continue reading
Comprehensive online program allows patients, caregivers, and families education, tools, and support systems specific to caring for cancer patients of all kinds.Continue reading
The award will go towards the development of CTX-002 in preparation for clinical studiesContinue reading
Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit during Arizona Bioscience WeekContinue reading
Renée Galá promoted to President and Chief Operating Officer
PHOENIX (September 14, 2023) – Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.Continue reading